Long-term outcome with cardiac resynchronization therapy in mild heart failure patients with left bundle branch block from US and Europe MADIT-CRT

Verfasser / Beitragende:
[Yitschak Biton, Valentina Kutyifa, Wojciech Zareba, Helmut Klein, Scott Solomon, Scott McNitt, Bronislava Polonsky, Arthur Moss, Ilan Goldenberg]
Ort, Verlag, Jahr:
2015
Enthalten in:
Heart Failure Reviews, 20/5(2015-09-01), 535-543
Format:
Artikel (online)
ID: 605479070
LEADER caa a22 4500
001 605479070
003 CHVBK
005 20210128100408.0
007 cr unu---uuuuu
008 210128e20150901xx s 000 0 eng
024 7 0 |a 10.1007/s10741-015-9499-2  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10741-015-9499-2 
245 0 0 |a Long-term outcome with cardiac resynchronization therapy in mild heart failure patients with left bundle branch block from US and Europe MADIT-CRT  |h [Elektronische Daten]  |c [Yitschak Biton, Valentina Kutyifa, Wojciech Zareba, Helmut Klein, Scott Solomon, Scott McNitt, Bronislava Polonsky, Arthur Moss, Ilan Goldenberg] 
520 3 |a Early intervention with cardiac resynchronization therapy with defibrillator (CRT-D) in mild heart failure (HF) patients with a left bundle branch block (LBBB) ECG pattern was associated with a significant reduction in mortality in the long-term MADIT-CRT trial. Whether patients in MADIT-CRT enrolled from centers in the USA and in Europe have different long-term clinical response to CRT-D remains unknown. We compared the baseline clinical characteristics and clinical and echocardiographic long-term clinical response to CRT-D between MADIT-CRT patients with LBBB who were enrolled in USA (n=871) and European centers (n=392). Although European patients had more advanced heart disease than US patients, CRT-D was associated with similar 60% (p<0.001) reductions in the risk of HF in US and European patients when compared to ICD-only therapy after adjustment for relevant baseline clinical covariates. US patients had significant long-term mortality reduction (38%, p=0.02) while among European patients the survival benefit associated with CRT-D was not statistically significant (HR 0.73, p=0.18); subgroup analyses revealed a significantly greater CRT-D benefit among women who were enrolled in the USA, whereas no significant gender difference in the clinical benefit of CRT-D was observed in the European cohort. Reverse remodeling at 1year was associated with significantly better clinical outcomes in both groups. Despite differences in baseline disease severity, European and US patients with LBBB experienced a similar clinical and echocardiographic response to cardiac resynchronization therapy during long-term follow-up. Clinical trial registration: http://clinicaltrials.gov/ct2/show/NCT00180271 . 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a Cardiac resynchronization therapy  |2 nationallicence 
690 7 |a Implantable cardioverter defibrillator  |2 nationallicence 
690 7 |a Mild heart failure  |2 nationallicence 
690 7 |a Mortality  |2 nationallicence 
690 7 |a Long-term survival  |2 nationallicence 
690 7 |a CRT : Cardiac resynchronization therapy  |2 nationallicence 
690 7 |a CRT-D : Cardiac resynchronization therapy with an implantable cardioverter defibrillator  |2 nationallicence 
690 7 |a HF : Heart failure  |2 nationallicence 
690 7 |a ICD : Implantable cardioverter defibrillator  |2 nationallicence 
690 7 |a LBBB : Left bundle branch block  |2 nationallicence 
690 7 |a LV : Left ventricular  |2 nationallicence 
690 7 |a LVEF : Left ventricular ejection fraction  |2 nationallicence 
690 7 |a LVESV : Left ventricular end-systolic volume  |2 nationallicence 
690 7 |a LVEDV : Left ventricular end-diastolic volume  |2 nationallicence 
690 7 |a LAV : Left atrial volume  |2 nationallicence 
690 7 |a NYHA : New York Heart Association  |2 nationallicence 
690 7 |a US : United States  |2 nationallicence 
690 7 |a BUN : Blood urea nitrogen  |2 nationallicence 
700 1 |a Biton  |D Yitschak  |u Heart Research Follow-Up Program, Division of Cardiology, Department of Medicine, University of Rochester Medical Center, 265 Crittenden Blvd., PO Box 653, 14642, Rochester, NY, USA  |4 aut 
700 1 |a Kutyifa  |D Valentina  |u Heart Research Follow-Up Program, Division of Cardiology, Department of Medicine, University of Rochester Medical Center, 265 Crittenden Blvd., PO Box 653, 14642, Rochester, NY, USA  |4 aut 
700 1 |a Zareba  |D Wojciech  |u Heart Research Follow-Up Program, Division of Cardiology, Department of Medicine, University of Rochester Medical Center, 265 Crittenden Blvd., PO Box 653, 14642, Rochester, NY, USA  |4 aut 
700 1 |a Klein  |D Helmut  |u Heart Research Follow-Up Program, Division of Cardiology, Department of Medicine, University of Rochester Medical Center, 265 Crittenden Blvd., PO Box 653, 14642, Rochester, NY, USA  |4 aut 
700 1 |a Solomon  |D Scott  |u Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA  |4 aut 
700 1 |a McNitt  |D Scott  |u Heart Research Follow-Up Program, Division of Cardiology, Department of Medicine, University of Rochester Medical Center, 265 Crittenden Blvd., PO Box 653, 14642, Rochester, NY, USA  |4 aut 
700 1 |a Polonsky  |D Bronislava  |u Heart Research Follow-Up Program, Division of Cardiology, Department of Medicine, University of Rochester Medical Center, 265 Crittenden Blvd., PO Box 653, 14642, Rochester, NY, USA  |4 aut 
700 1 |a Moss  |D Arthur  |u Heart Research Follow-Up Program, Division of Cardiology, Department of Medicine, University of Rochester Medical Center, 265 Crittenden Blvd., PO Box 653, 14642, Rochester, NY, USA  |4 aut 
700 1 |a Goldenberg  |D Ilan  |u Heart Research Follow-Up Program, Division of Cardiology, Department of Medicine, University of Rochester Medical Center, 265 Crittenden Blvd., PO Box 653, 14642, Rochester, NY, USA  |4 aut 
773 0 |t Heart Failure Reviews  |d Springer US; http://www.springer-ny.com  |g 20/5(2015-09-01), 535-543  |x 1382-4147  |q 20:5<535  |1 2015  |2 20  |o 10741 
856 4 0 |u https://doi.org/10.1007/s10741-015-9499-2  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10741-015-9499-2  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Biton  |D Yitschak  |u Heart Research Follow-Up Program, Division of Cardiology, Department of Medicine, University of Rochester Medical Center, 265 Crittenden Blvd., PO Box 653, 14642, Rochester, NY, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kutyifa  |D Valentina  |u Heart Research Follow-Up Program, Division of Cardiology, Department of Medicine, University of Rochester Medical Center, 265 Crittenden Blvd., PO Box 653, 14642, Rochester, NY, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Zareba  |D Wojciech  |u Heart Research Follow-Up Program, Division of Cardiology, Department of Medicine, University of Rochester Medical Center, 265 Crittenden Blvd., PO Box 653, 14642, Rochester, NY, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Klein  |D Helmut  |u Heart Research Follow-Up Program, Division of Cardiology, Department of Medicine, University of Rochester Medical Center, 265 Crittenden Blvd., PO Box 653, 14642, Rochester, NY, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Solomon  |D Scott  |u Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a McNitt  |D Scott  |u Heart Research Follow-Up Program, Division of Cardiology, Department of Medicine, University of Rochester Medical Center, 265 Crittenden Blvd., PO Box 653, 14642, Rochester, NY, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Polonsky  |D Bronislava  |u Heart Research Follow-Up Program, Division of Cardiology, Department of Medicine, University of Rochester Medical Center, 265 Crittenden Blvd., PO Box 653, 14642, Rochester, NY, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Moss  |D Arthur  |u Heart Research Follow-Up Program, Division of Cardiology, Department of Medicine, University of Rochester Medical Center, 265 Crittenden Blvd., PO Box 653, 14642, Rochester, NY, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Goldenberg  |D Ilan  |u Heart Research Follow-Up Program, Division of Cardiology, Department of Medicine, University of Rochester Medical Center, 265 Crittenden Blvd., PO Box 653, 14642, Rochester, NY, USA  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Heart Failure Reviews  |d Springer US; http://www.springer-ny.com  |g 20/5(2015-09-01), 535-543  |x 1382-4147  |q 20:5<535  |1 2015  |2 20  |o 10741